Showing results (251-260 of 337) with videos related to

Sort By:
Pageof 34
American Heart Journal|August 9, 2005
Improved long-term survival associated with stent deployment during percutaneous coronary interventions: results from a registry of 3399 patientsJoseph B Muhlestein, Jeffrey L Anderson, ChangZong Cui, et al.
Circulation. Arrhythmia and Electrophysiology|February 18, 2014
Percutaneous left ventricular assist devices in ventricular tachycardia ablation: multicenter experienceYeruva Madhu Reddy, Larry Chinitz, Moussa Mansour, et al.
The American Journal of Cardiology|June 6, 2013
Validation and quantification of genetic determinants of lipoprotein-a levels and predictive value for angiographic coronary artery diseaseJeffrey L Anderson, Stacey Knight, Heidi T May, et al.
Open Heart|December 20, 2018
Improving CHA2DS2-VASc stratification of non-fatal stroke and mortality risk using the Intermountain Mortality Risk Score among patients with atrial fibrillationKevin G Graves, Heidi T May, Kirk U Knowlton, et al.
The American Journal of Cardiology|April 15, 2019
Safety and Efficacy of Periprocedural Heparin Plus a Short-Term Infusion of Tirofiban Versus Bivalirudin Monotherapy in Patients Who Underwent Percutaneous Coronary Intervention (from the Intermountain Heart Institute STAIR Observational Registry)Joseph B Muhlestein, Ian S Hackett, Heidi T May, et al.
The Journal of Invasive Cardiology|March 5, 2008
Real-world safety and efficacy of glycoprotein IIb/IIIa inhibitors during percutaneous coronary interventionPeter J Casterella, James R Revenaugh, James L Burke, et al.
European Journal of Preventive Cardiology|October 21, 2015
The utility of the apolipoprotein A1 remnant ratio in predicting incidence coronary heart disease in a primary prevention cohort: The Jackson Heart StudyHeidi T May, John R Nelson, Seth T Lirette, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|April 1, 2022
Intermittent fasting and changes in Galectin-3: A secondary analysis of a randomized controlled trial of disease-free subjectsBenjamin D Horne, Jeffrey L Anderson, Heidi T May, et al.
The American Journal of Cardiology|August 19, 2007
Validation of the Seattle Heart Failure Model in a community-based heart failure population and enhancement by adding B-type natriuretic peptideHeidi T May, Benjamin D Horne, Wayne C Levy, et al.
Journal of Electrocardiology|November 28, 2017
Smartphone ECG for evaluation of ST-segment elevation myocardial infarction (STEMI): Design of the ST LEUIS International Multicenter StudyAlejandro Barbagelata, Charles F Bethea, Harry W Severance, et al.
Pageof 34